UA84462C2 - Полиморфные модификации кислотно-аддитивных солей иматиниба с метансульфоновой кислотой - Google Patents

Полиморфные модификации кислотно-аддитивных солей иматиниба с метансульфоновой кислотой

Info

Publication number
UA84462C2
UA84462C2 UAA200611573A UAA200611573A UA84462C2 UA 84462 C2 UA84462 C2 UA 84462C2 UA A200611573 A UAA200611573 A UA A200611573A UA A200611573 A UAA200611573 A UA A200611573A UA 84462 C2 UA84462 C2 UA 84462C2
Authority
UA
Ukraine
Prior art keywords
imatinib
acid addition
methanesulfonic acid
addition salts
crystalline polymorphs
Prior art date
Application number
UAA200611573A
Other languages
English (en)
Ukrainian (uk)
Inventor
Войцех Щепек
Дорота Самсон-Лазинска
Богдан Загродзки
Магдалена Глице
Виолета Марушак
Катаржина Корчак
Ришард Модзелевски
Марта Лавецка
Лукаш Качмарек
Веслав Шелеевски
Уршула Фрачек
Петр Цмох
Original Assignee
Институт Фармацевтични
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL366885A external-priority patent/PL216883B1/pl
Application filed by Институт Фармацевтични filed Critical Институт Фармацевтични
Priority claimed from PL374074A external-priority patent/PL374074A1/pl
Publication of UA84462C2 publication Critical patent/UA84462C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UAA200611573A 2004-04-02 2005-02-04 Полиморфные модификации кислотно-аддитивных солей иматиниба с метансульфоновой кислотой UA84462C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PL366885A PL216883B1 (pl) 2004-04-02 2004-04-02 Sposób wytwarzania krystalicznej formy a soli addycyjnej kwasu metanosulfonowego i 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2- -yloamino)fenylo]benzamidu
PL374074A PL374074A1 (pl) 2005-04-01 2005-04-01 Sposób wytwarzania krystalicznej formy Ó monomesylanu 4-(4-metylopiperazyn-1-ylometylo)-N-[4-metylo-3-[(4-pirydyn-3-ylo)pirymidyn-2-yloamino]fenylo]benzamidu
PCT/PL2005/000024 WO2005095379A2 (en) 2004-04-02 2005-04-02 Crystalline methanesulfonic acid addition salts of imatinib

Publications (1)

Publication Number Publication Date
UA84462C2 true UA84462C2 (ru) 2008-10-27

Family

ID=34981470

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200611573A UA84462C2 (ru) 2004-04-02 2005-02-04 Полиморфные модификации кислотно-аддитивных солей иматиниба с метансульфоновой кислотой

Country Status (5)

Country Link
US (1) US7732601B2 (ru)
EP (1) EP1742933A2 (ru)
IL (1) IL178097A (ru)
UA (1) UA84462C2 (ru)
WO (1) WO2005095379A2 (ru)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE43932E1 (en) 1997-07-18 2013-01-15 Novartis Ag Crystal modification of a N-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
WO2006024863A1 (en) * 2004-09-02 2006-03-09 Cipla Limited Stable crystal form of imatinib mesylate and process for the preparation thereof
WO2006048890A1 (en) * 2004-11-04 2006-05-11 Sun Pharmaceutical Industries Limited Imatinib mesylate crystal form and process for preparation thereof
WO2006054314A1 (en) * 2004-11-17 2006-05-26 Natco Pharma Limited Polymorphic forms of imatinib mesylate
EP1922314A1 (en) 2005-08-26 2008-05-21 Novartis AG Delta and epsilon crystal forms of imatinib mesylate
AU2006316823A1 (en) 2005-11-25 2007-05-31 Novartis Ag F,G,H,I and K crystal forms of imatinib mesylate
US7977348B2 (en) 2006-04-27 2011-07-12 Sicor Inc. Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
EP1919893A2 (en) 2006-04-27 2008-05-14 Sicor, Inc. Polymorphic forms of imatinib mesylate and processes for their preparation as well as of amorphous imatinib mesylate and form alpha
US8067421B2 (en) 2006-04-27 2011-11-29 Sicor Inc. Polymorphic forms of imatinib mesylate and processes for preparation of novel crystalline forms as well as amorphous and form α
US20060223816A1 (en) * 2006-05-08 2006-10-05 Chemagis Ltd. Imatinib mesylate alpha form and production process therefor
EP2009008A1 (en) 2006-10-26 2008-12-31 Sicor, Inc. Imatinib base, and imatinib mesylate and processes for preparation thereof
US7550591B2 (en) 2007-05-02 2009-06-23 Chemagis Ltd. Imatinib production process
US20090012296A1 (en) * 2007-05-29 2009-01-08 Alexandr Jegorov Processes for the preparation of crystalline form beta of imatinib mesylate
BRPI0817946A2 (pt) * 2007-09-25 2015-05-05 Teva Pharma Composições de imatinibe estável
US7947699B2 (en) 2008-01-10 2011-05-24 Actavis Group Ptc Ehf Anhydrous amorphous imatinib mesylate
US20100330130A1 (en) 2009-05-22 2010-12-30 Actavis Group Ptc Ehf Substantially pure imatinib or a pharmaceutically acceptable salt thereof
CZ2009570A3 (cs) 2009-08-26 2011-03-09 Zentiva, K. S. Príprava, stabilizace a využití polymorfu imatinib mesylátu pro vývoj lékových forem
PL389357A1 (pl) 2009-10-22 2011-04-26 Tomasz Koźluk Sole imatinibu z pochodnymi kwasów winowych i sposób ich wytwarzania
WO2011095835A1 (en) 2010-02-02 2011-08-11 Actavis Group Ptc Ehf Highly pure imatinib or a pharmaceutically acceptable salt thereof
WO2011100282A2 (en) * 2010-02-09 2011-08-18 Dr. Reddy's Laboratories Ltd. Imatinib mesylate polymorphs
AU2011213936A1 (en) 2010-02-15 2012-09-06 Sharma Ashwani Process for the preparation of alpha form of imatinib mesylate
PL390611A1 (pl) 2010-03-04 2011-09-12 Tomasz Koźluk Sposób otrzymywania polimorficznej formy alfa i nowa forma polimorficzna mesylanu imatinibu
KR20130055576A (ko) 2010-03-15 2013-05-28 낫코 파마 리미티드 고순도의 결정질 이마티닙 염기를 제조하는 방법
WO2011130918A1 (zh) 2010-04-23 2011-10-27 上海百灵医药科技有限公司 一种伊马替尼的合成方法
WO2011158255A1 (en) * 2010-06-16 2011-12-22 Aptuit Laurus Private Limited Process for preparation of stable imatintb mesylate alpha form
WO2011157450A1 (en) 2010-06-18 2011-12-22 Krka, D. D., Novo Mesto New polymorphic form of imatinib base and preparation of salts thereof
WO2012014000A1 (en) * 2010-07-30 2012-02-02 Ramesh Babu Potluri STABLE α-CRYSTAL FORM OF IMATINIB MESYLATE AND PREPARING PROCESS THEREOF
CN102146073A (zh) * 2011-02-23 2011-08-10 江苏先声药物研究有限公司 一种伊玛替尼甲烷磺酸盐α晶型新的制备方法
PL394169A1 (pl) 2011-03-09 2012-09-10 Adamed Spółka Z Ograniczoną Odpowiedzialnością Kompozycja farmaceutyczna metanosulfonianu imatinibu do napełniania jednostkowych postaci dawkowania oraz sposób jej wytwarzania
EP2691385A4 (en) 2011-03-31 2014-08-13 Ind Swift Lab Ltd IMPROVED METHOD FOR THE PRODUCTION OF IMATINIB AND ITS MESYLATE SALT
CN102321070B (zh) * 2011-07-27 2013-05-22 江苏先声药物研究有限公司 反溶剂重结晶法制备伊玛替尼甲烷磺酸盐α晶型
IN2012DE00728A (ru) 2012-03-13 2015-08-21 Fresenius Kabi Oncology Ltd
CN102617552A (zh) * 2012-04-06 2012-08-01 江南大学 一种制备α晶型甲磺酸伊马替尼的结晶方法
CN102633775B (zh) * 2012-04-06 2013-07-17 江南大学 一种甲磺酸伊马替尼α晶型的制备方法
CN103467446A (zh) * 2012-06-05 2013-12-25 广东东阳光药业有限公司 一种甲磺酸伊马替尼α晶型的制备方法
KR101242955B1 (ko) * 2012-06-25 2013-03-12 제일약품주식회사 이마티닙 메실레이트 결정형 α의 제조 방법
CN103570677B (zh) * 2012-08-02 2017-03-01 广东东阳光药业有限公司 一种α晶型甲磺酸伊马替尼的制备方法
CN103570674A (zh) * 2012-08-04 2014-02-12 浙江九洲药业股份有限公司 一种甲磺酸伊马替尼α晶型的制备方法
CN103058991A (zh) * 2012-12-28 2013-04-24 南京艾德凯腾生物医药有限责任公司 一种α晶型甲磺酸伊马替尼的制备方法
EP2749557A1 (en) 2012-12-31 2014-07-02 Deva Holding Anonim Sirketi Process for preparation of alpha polymorph of imatinib mesylate from IPA and THF solvate forms of imatinib mesylate
ES2683361T3 (es) 2013-05-14 2018-09-26 Hetero Research Foundation Composiciones de Imatinib
EP3007699A4 (en) * 2013-06-12 2017-01-18 Shilpa Medicare Limited Crystalline imatinib mesylate process
CN103483314B (zh) * 2013-09-16 2015-02-18 南京优科生物医药研究有限公司 一种便捷的制备甲磺酸伊马替尼α晶型的方法
WO2017078647A1 (en) 2015-11-05 2017-05-11 Koçak Farma Ilaç Ve Kimya Sanayi Anonim Şirketi Pharmaceutical compositions of imatinib
WO2020128990A1 (en) * 2018-12-21 2020-06-25 Pirelli Tyre S.P.A. Capsules comprising vulcanisation accelerant agents, their preparation and use in the vulcanisation of elastomeric compounds for tyres

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4940418A1 (es) * 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
US20060052387A1 (en) 2002-06-26 2006-03-09 Marsh Clay B Organic compounds

Also Published As

Publication number Publication date
IL178097A (en) 2013-03-24
EP1742933A2 (en) 2007-01-17
WO2005095379A3 (en) 2006-05-18
WO2005095379B1 (en) 2006-07-13
US20070197545A1 (en) 2007-08-23
US7732601B2 (en) 2010-06-08
IL178097A0 (en) 2006-12-31
WO2005095379A2 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
UA84462C2 (ru) Полиморфные модификации кислотно-аддитивных солей иматиниба с метансульфоновой кислотой
CL2007002949A1 (es) Forma cristalina del compuesto 2-cloro-5-(3,6-dihidro-3-metil-2,6-dioxo-4-(trifluorometil)-1-(2h)-pirimidinil)-4-fluoro-n-((metil(1-metiletil)amino)sulfonil)benzamida; proceso para la preparacion de dicha forma cristalina; composicion fitoprotectora;
WO2008094992A3 (en) 2-aminopyridine derivatives useful as kinase inhibitors
NZ592533A (en) METHOD FOR THE PREPARATION OF N-(5-CHLORO-2-PYRIDINYL)-2-[[4-[(DIMETHYLAMINO) IMINOMETHYL] BENZOYL] AMINO]-5-METHOXY-BENZAMIDE, A FACTOR Xa INHIBITOR
EA200800728A1 (ru) Полиморфы бензоатной соли 2-[[6-[(3r)-3-амино-1-пиперидинил]-3,4-дигидро-3-метил-2,4-диоксо-1(2н)-пиримидинил]метил]бензонитрила и способы их применения
MY148375A (en) Delta and epsilon crystal forms of imatinib mesylate
EA200901514A1 (ru) Новая сольватная и кристаллическая форма производных карбамоилциклогексана
MX2010003849A (es) Antagonistas de cgrp.
PE20051096A1 (es) Formas de sal de 4-(4-metilpiperazin-1-ilmetil)-n-[4-metil-3-(4-piridin-3-il)pirimidin-2-ilamino)fenil]-benzamida
BRPI0515081B8 (pt) composto, processo para a preparação de um sal de guanidino trifluormetilaroil amida, processo para a preparação de um fenil amino pirido pirimidina, composições farmacêuticas e processos para preparar (3,5-bis trifluormetil)-n-[4-metil-3-(4-piridin-3-il-pirimidin-2-ilamino)-fenil]-benzamida
WO2013150545A3 (en) Process for preparation of benzimidazole derivatives and salts thereof
WO2008059551A3 (en) Process for the preparation of imatinib and intermediates thereof
MY148769A (en) Process for the synthesis of derivatives of 3-amino-tetrahydrofuran-3-carboxylic acid and use thereof as medicaments
DE602005023658D1 (de) Verfahren zur herstellung von imatinib-base
EA201170736A1 (ru) Синтез и новые солевые формы (r)-3-((e)-2-(пирролидин-3-ил)винил)-5-(тетрагидропиран-4-илокси) пиридина
MX2011008178A (es) Derivados de pirrolidina como antagonistas del receptor de neuroquinina 3 (nk3).
ZA200804858B (en) Sulfoximine derivatives as p38 map kinase inhibitors
IL188109A0 (en) Chloro-substituted guanidines
UA101816C2 (en) Polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide
WO2006100026A8 (de) 2-oxo-1,2,4,5-tetrahydro-1,3-benzdiazepin-3-yl-piperidine als cgrp-antagonisten
WO2006133904A3 (en) Methods and intermediates for the preparation of optionally radio-labeled imatinib
DE602005008095D1 (de) Verfahren zur herstellung von isonikotinsäurederivaten
NO20064114L (no) Fremgangsmate for fremstilling av N-arylpiperazinderivater
EA201001095A1 (ru) Соединение (r)-n*6*-этил-6,7-дигидро-5н-индено[5,6-d]тиазол-2,6-диамин и его применение в качестве антипсихотического средства
TW200613283A (en) 3-(4-piperidinyl)-2,3,4,5-tetrahydro-1,3-benzodiazepin-2(1H)-one